πŸ‡ΊπŸ‡Έ FDA
Preview mode β€” showing bulk-ingested data not yet promoted to production. Hide preview

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
3,385
Companies
1,062
Pipeline programs
18,156

Quick answer

NovaPharmaNews tracks 3,385 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 5 of 142 Β· A–Z by INN

  1. alectinib

    ALECENSA

    L01ED03

  2. alectinib hydrochloride

    ALECENSA

    ORAL approved

  3. alemtuzumab

    LEMTRADA

    INJECTION approved

    L04AA34

  4. alendronate sodium

    ALENDRONATE SODIUM Teva Pharma GmbH

    ORAL approved

  5. alendronate sodium trihydrate

    ALENDRONIC ACID / COLECALCIFEROL MYLAN

    M05BB03

  6. alendronic acid

    VANTAVO (PREVIOUSLY ALENDRONATE SODIUM AND COLECALCIFEROL, MSD)

    M05BB03

  7. alfentanil hydrochloride

    ALFENTA

    INJECTION approved

  8. alfuzosin hydrochloride

    ALFUZOSIN HYDROCHLORIDE

    ORAL approved

  9. alglucosidase alfa

    MYOZYME

    IV (INFUSION) approved

    A16AB07

  10. alipogene tiparvovec

    GLYBERA

    C10AX10

  11. alirocumab

    PRALUENT Regeneron UK Limited

    INJECTION approved

    C10AX14

  12. aliskiren

    RASILEZ Lxo Ireland Designated Activity Company

    C09XA02

  13. aliskiren hemifumarate

    RASILAMLO

    ORAL approved

    C09XA53

  14. alitretinoin

    PANRETIN

    TOPICAL approved

    L01XX22

  15. alkavervir

    VERILOID

    ORAL approved

  16. allogeneic t cells genetically modified with a retroviral vector encoding for a truncated form of the human low affinity nerve growth factor receptor (Ξ΄lngfr) and the herpes simplex i virus thymidine kinase (hsv-tk mut2)

    ZALMOXIS

    L01

  17. allogeneic umbilical cord-derived cd34- cells, non-expanded

    ZEMCELPRO

    B05AX04

  18. allopurinol

    DUZALLO IRONWOOD PHARMACEUTICALS INC

    ORAL approved

    M04AA51

  19. allopurinol sodium

    ALLOPURINOL SODIUM

    INJECTION approved

  20. almotriptan malate

    ALMOTRIPTAN MALATE Teva Pharma GmbH

    ORAL approved

  21. alogliptin

    INCRESYNC Takeda Pharmaceuticals International AG

    ORAL approved

    A10BD13

  22. alogliptin and metformin hydrochloride

    ALOGLIPTIN AND METFORMIN HYDROCHLORIDE

    ORAL approved

  23. alogliptin benzoate

    VIPIDIA Takeda Pharmaceuticals International AG

    ORAL approved

    A10BH04

  24. alosetron hydrochloride

    ALOSETRON HYDROCHLORIDE Amneal Pharma Europe Ltd

    ORAL approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 3,385 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources